[1T07] Biology of Diseases 02

11:59 AM - 12:08 PM JST(2:59 AM - 3:08 AM UTC)

[1T07-07] Regulation of the interaction of BCR-ABL with VDAC1 can function as a novel therapeutic strategy against CML.

^○Yuta Okuda¹, Miho Takahashi¹, Aoi Ikegami¹, Norihito Shibata², Mikihiko Naito³, Kiyotaka Nishikawa¹ (1.Molecular Life Sciences Laboratory, Faculty of Life and Medical Sciences, Doshisha University, 2.Division of Biochemistry, National Institute of Health Sciences, 3.Laboratory of Targeted Protein Degradation, Graduate School of Pharmaceutical Sciences, The University of Tokyo)

キーテクノロジー：BioID法

Keywords:

BCR-ABL、PHドメイン、ミトコンドリア、アポトーシス、VDAC1

[e-mail]

Password required to view